An AllTrials project

NCT01976936: A trial that was reported late by Mitchell S Elkind

This trial has reported, although it was 57 days late in doing so.

Full data

Full entry on NCT01976936
Title A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Results Status Reported (late)
ACT or pACT? This is what FDAAA officially calls a "probable Applicable Clinical Trial"
Start date Feb. 28, 2009
Completion date Jan. 31, 2017
Required reporting date Jan. 31, 2018, midnight
Actual reporting date March 29, 2018
Date last checked at Sept. 20, 2021
Days late 57